California SB950 mandates health insurance coverage for FDA-approved Alzheimer’s treatments, banning step therapy protocols.

California SB950 requires health insurance policies to cover FDA-approved treatments for Alzheimer’s disease and related memory conditions, effective January 1, 2027. It prohibits health insurers from using step therapy protocols as a prerequisite for covering these treatments. The bill also mandates that coverage criteria for these treatments cannot be more restrictive than FDA-approved indications. This provision does not apply to vision-only, dental-only, accident-only, specified disease, hospital indemnity, or Medicare supplement insurance policies.

California SB950 mandates health insurance coverage for FDA-approved Alzheimer’s treatments, banning step therapy protocols.

California SB950 requires health insurance policies to cover FDA-approved treatments for Alzheimer’s disease and related memory conditions, effective January 1, 2027. It prohibits health insurers from using step therapy protocols as a prerequisite for covering these treatments. The bill also mandates that coverage criteria for these treatments cannot be more restrictive than FDA-approved indications. This provision does not apply to vision-only, dental-only, accident-only, specified disease, hospital indemnity, or Medicare supplement insurance policies.